What platforms support n-of-1 therapy design or personalized medicine workflows?

The landscape of n-of-1 therapy design and personalized medicine workflows is shifting from academic theory toward dedicated digital health frameworks and software platforms . An n-of-1 trial treats a single individual as a complete entity—cycling through randomized intervention and control periods to figure out what uniquely works best for that specific patient rather than relying on population averages.pmc.ncbi.nlm.nih.gov+1

Several notable platforms, software engines, and open-source ecosystems support n-of-1 trials and personalized optimization workflows:

• StudyU Platform
  • What it is: A fully functional, open-source digital health platform specifically built for designing and conducting n-of-1 trials and single-case experimental designs (SCEDs).
  • Components: It features the StudyU Designer (a collaborative web application for researchers and clinicians to digitally specify, configure, and publish trials) paired with the StudyU App (a patient-facing smartphone app for tracking interventions and reporting real-time health data).
  • Best for: Researchers, clinicians, and digital health developers wanting an open-source, self-hostable ecosystem with high data privacy standards. You can explore the tool at the StudyU Platform or access its configuration workspace via the StudyU Designer.studyu.health+1
• CURATE.AI / CURATE.Dtx Engine
  • What it is: A pioneering artificial intelligence platform and optimization tool designed to continuously calibrate personalized dosing or therapeutic regimens. Rather than a static one-size-fits-all plan, it uses small amounts of individual patient data over time to map out individualized response profiles.
  • Application: It has been deployed across clinical trials in oncology, digital therapeutics (DTx), hypertension, and cardiorespiratory performance optimization. Regulatory bodies (such as Singapore's HSA) have evaluated specific implementations of the CURATE.AI software framework as classified medical devices for dosage/intensity recommendations.
  • Best for: Advanced digital therapeutic tracking and AI-driven dynamic individualized dose optimization.pmc.ncbi.nlm.nih.gov+1
• N-of-1 Hub
  • What it is: A specialist clinical and methodological consultancy/collaboration platform that partners with pharma, med-tech, digital health, and academic researchers.
  • Services & Workflow Support: While not a standalone software download, they provide rigorous operational scaffolding, setting up dedicated databases, generating individual randomization sequences, and executing specialized n-of-1 data analytics.
  • Best for: Clinical teams and organizations needing end-to-end design protocols, training, and complex statistical analysis for n-of-1 trials. Learn more via the N-of-1 Hub.n-of-1hub.com+2
• Custom R/Python Statistical Packages (Academic & Clinical Infrastructure)
  • What it is: For custom enterprise or institutional workflows, much of the heavy lifting in n-of-1 analysis is driven via specialized open-source statistical libraries (such as R packages designed for single-case data analysis like scan or multilevel modeling frameworks). Many hospital systems build internal personalized dashboards that feed electronic health record (EHR) data into localized Bayesian n-of-1 analytical models.

Would you like to explore how to set up a study on StudyU , or are you looking for guidance on the statistical modeling methods used to analyze n-of-1 trial data?

Supporting platforms for n-of-1 trial design and personalized medicine workflows bridge the gap between traditional population-based clinical data and individual, patient-centric optimization. While many commercial electronic health record (EHR) systems lack native n-of-1 trial capabilities, dedicated digital health frameworks, open-source software, and AI-driven platforms have emerged to fill this space.pmc.ncbi.nlm.nih.gov+1

Dedicated N-of-1 and Personalized Trial Platforms

• StudyU : An open-source platform specifically built for designing and conducting digital n-of-1 trials . It splits into the StudyU Designer (a web app for researchers/clinicians to map out intervention sequences, schedules, and metrics) and a companion mobile app for real-time patient tracking and feedback.studyu.health+1
• StudyMe : A mobile-centric framework designed for user-centric n-of-1 trials, allowing individuals and clinicians to structure comparative tests on lifestyle, supplements, or minor therapeutic interventions.pmc.ncbi.nlm.nih.gov
• Legacy/Condition-Specific Apps : Smaller niche tools like TummyTrials (for IBS dietary tracking) and SleepCoacher (for iterative sleep adjustments) demonstrate how single-condition n-of-1 workflows can be operationalized via guided micro-experiments.pmc.ncbi.nlm.nih.gov

AI and Mathematical Modeling Frameworks for N-of-1 Dosing

• CURATE.AI : A proprietary AI/machine learning platform that treats each patient as a discrete case rather than relying on population big data. It uses proprietary algebraic-neural modeling based strictly on an individual's incoming clinical or digital therapeutic data to dynamically adjust and optimize drug dosing (e.g., in oncology or post-transplant care).frontiersin.org+1
• QPOP (Quantitative Personalized Optimization Platform) : A computational platform used to analyze individual multi-omics or ex-vivo drug response profiles to predict optimal drug combinations for patients failing standard therapies.frontiersin.org

Academic and Enterprise Clinical Trial Solutions

• Custom EDC (Electronic Data Capture) systems : Many academic medical centers adapt traditional flexible enterprise EDC platforms (such as REDCap or ClinCapture) by building custom repeating branching logic and randomized crossover schedules to mimic n-of-1 trial constraints manually.

If you're looking to implement a workflow, tell me:

• Are you designing a clinical research study or looking for a clinical care tool for individual patients?
• What type of intervention (pharmacological, dietary, digital) are you hoping to track?

I can help narrow down whether an open-source framework or a custom clinical protocol fits best.

Yes. The ecosystem is still relatively small, and it helps to distinguish true N-of-1 trial platforms from broader personalized-medicine/genomics platforms.

Platforms specifically suited to N-of-1 / single-patient experiments

• studyu.health — probably the clearest fit if you want an end-to-end N-of-1 workflow. It provides a web-based StudyU Designer for specifying trials and a participant app for running them, collecting outcomes, and analyzing/reporting results. It is open source and designed around personalized interventions.PubMed Central (PMC)+1
• StudyMe — a research-developed mobile application for people to create and run highly customizable N-of-1 experiments themselves. It is particularly oriented toward self-experimentation rather than clinical-trial infrastructure.PubMed Central (PMC)
• PACO — a mobile/web experience-sampling platform that has been used for flexible individual-level intervention studies. It can collect data for N-of-1 designs, although the literature notes that it does not provide the same integrated statistical analysis/reporting workflow as StudyU.PubMed Central (PMC)+1
• movisensXS — flexible mobile data-collection infrastructure that can support individual-level/N-of-1 studies, particularly when intensive longitudinal or sensor data are important. It is more of a data-collection platform than a complete N-of-1 decision system.JMIR
• OpenClinica — electronic clinical-data capture and study-management infrastructure that can be adapted to individual studies, but it isn't purpose-built around the N-of-1 workflow or personalized treatment interpretation.JMIR

A useful historical comparison from the AHRQ work on N-of-1 infrastructure is MyIBD, which implemented a personalized-learning-system approach for inflammatory bowel disease, including individualized treatment experiments and longitudinal outcome monitoring. It illustrates the sort of architecture needed for clinical N-of-1 care, although it isn't a general commercial product.Effective Healthcare+1

Personalized-medicine platforms, but not necessarily N-of-1 trials

There is a second category: platforms that personalize therapy selection or therapeutic development using genomic/clinical data rather than repeatedly randomizing treatments within one patient.

• nome.bio — focuses on personalized genetic medicines, particularly rare-disease cases. Its workflow spans patient-case analysis, therapeutic design, and clinical execution. This is closer to individualized therapeutic development than an N-of-1 crossover trial.Nome

What I'd look for in a serious N-of-1 workflow

If you're evaluating platforms for a clinical or research program, the important distinction is whether they actually support:

1. Protocol design — A/B, ABAB, randomized crossover, withdrawal/reversal, adaptive or sequential designs.
2. Within-person randomization rather than merely longitudinal tracking.
3. Treatment-period management — adherence, washout, carryover, deviations.
4. High-frequency outcome collection from apps, wearables, sensors, or EHRs.
5. Individual-level statistical analysis, rather than simply plotting trends.
6. Clinician + patient reporting and shared interpretation.
7. Aggregation across N-of-1 trials so individual experiments can contribute to population-level evidence.
8. EHR/API integration, particularly if the goal is clinical deployment.

Those capabilities are important because an N-of-1 platform is substantially more than a patient-monitoring app: the intended workflow runs from defining the clinical question through intervention randomization, repeated measurement, statistical analysis, and interpretation with the patient.Effective Healthcare+1

Bottom line: if your primary requirement is actual N-of-1 trial execution, StudyU is the most directly aligned currently visible platform. If your requirement is personalized therapeutic development, particularly rare-disease genetic medicines, Nome represents a different and complementary category.

If you tell me whether you're looking for (a) a platform to use clinically, (b) an API/SDK to build on, or (c) infrastructure for a research study, I can narrow this to the relevant 5–10 options and compare their APIs, randomization, analytics, EHR integration, hosting, and cost.

Several specialized digital platforms, artificial intelligence engines, and decentralized trial frameworks support n-of-1 therapy design and personalized medicine workflows , shifting clinical management from population averages to individual-centric optimization.pmc.ncbi.nlm.nih.gov+1

Because n-of-1 trials and personalized pathways require continuous longitudinal data capture, dynamic dose optimization, and tailored intervention tracking, distinct software ecosystems have emerged to address these workflows.frontiersin.org

Key Platforms Supporting N-of-1 and Personalized Workflows

• CURATE.AI / COR-Tx Platform : An artificial intelligence-based digital health platform that utilizes a patient's own internal clinical or phenotypic data to dynamically optimize dosing and combination therapy in real time. It eliminates population-based fixed sizing by calibrating therapeutic intensity (such as digital cognitive training or drug dosages) strictly using individual longitudinal performance.pmc.ncbi.nlm.nih.gov+1
• Mobile Health & Wireless Monitoring Frameworks : Platforms utilizing consumer or clinical-grade remote patient monitoring (RPM) integrated via customized smartphone ecosystems (such as ResearchKit-based applications) allow serial, at-home symptom tracking, cognitive assessments, and adverse-effect diaries essential for multi-crossover n-of-1 trials.mayoclinicplatform.org
• Ex Vivo and Organoid Precision Platforms : Laboratory-to-digital translational platforms (such as automated high-throughput ex vivo drug screening on patient-derived organoids) generate personalized response profiles for oncology and rare diseases, feeding individual sensitivity metrics directly into clinical decision support (CDS) pipelines.pmc.ncbi.nlm.nih.gov
• Custom Academic & Consortium Infrastructure : Frameworks developed via specialized academic health centers (such as pilot resources associated with the Mayo Clinic Platform or institutional precision medicine unit tools) offer custom-built trial prototypes, e-consent, and localized pharmacy integration to reduce administrative barriers in deploying individual-centered trials.nam.edu+1

Core Capabilities Comparison

If you have a specific condition or use case in mind, tell me:

• The medical specialty (e.g., oncology, neurology, psychiatry, rare disease)
• Whether you are looking for tools for clinical research or direct patient care

I can help narrow down the most relevant software or framework.

Yes. There are several platforms, but they fall into two fairly different categories: purpose-built N-of-1 platforms and broader decentralized/personalized-trial infrastructure.

Platform	N-of-1 design	Data collection	Analysis/results	Best fit
StudyU	Strong, flexible	Web + mobile	Built-in statistical evaluation	Researchers/clinicians wanting end-to-end digital N-of-1
N-of-1 Hub	Strong, with expert support	Managed/custom	R/SPSS, time-series methods	Organizations wanting methodological + operational support
Eureka	Can support individualized/N-of-1 studies	Mobile/web, remote data	Study-dependent	Large-scale decentralized research
Evidation / similar DCT platforms	Configurable rather than N-of-1-native	Wearables, surveys, digital measures	Study-dependent	Larger personalized/decentralized studies
StudyMe	Highly customizable self-experimentation	Mobile	Individual-level evaluation	Consumer/self-directed N-of-1 research
Trialist	Purpose-built N-of-1	iOS/Android/web	Yes	Chronic-pain personalized trials
N-of-1 Health	Personalized health research	Longitudinal health data	Biostatistical/outcomes focus	Genetic medicine/disease communities

1. StudyU — closest to a true N-of-1 platform

StudyU is probably the clearest example of an end-to-end digital N-of-1 workflow. It has a web-based Designer for specifying studies and a participant app for conducting them. It is open source and supports self-hosting.www.studyu.health

The underlying publication describes capabilities including flexible trial design, intervention/outcome specification, participant-facing execution, and automated statistical evaluation.pmc.ncbi.nlm.nih.gov

Useful if your workflow is:
patient → define intervention/comparator → randomize periods → collect repeated outcomes → analyze individual treatment effect → return personalized result

2. N-of-1 Hub — methodology + managed infrastructure

N-of-1 Hub is less of a self-service SaaS product and more of a specialist N-of-1 clinical-trials consultancy. It offers trial design, protocol support, randomization, data management, analysis, and individual participant reporting.www.n-of-1hub.com+2

This is particularly relevant if you're building a clinical program and need statistical/methodological expertise rather than just an app.

3. Eureka — broader decentralized infrastructure

Eureka isn't fundamentally an N-of-1 product, but it has been used for individualized trials. A particularly interesting example is I-STOP-AFib, where the Eureka platform supported an individualized/N-of-1 intervention study involving hundreds of participants.pmc.ncbi.nlm.nih.gov

So it is better thought of as:

DCT infrastructure → configurable individualized study

rather than:

N-of-1 engine → everything optimized around one patient.

4. StudyMe — highly personalized self-experimentation

StudyMe research description describes a mobile app specifically designed to let users create and run customizable N-of-1 trials.pmc.ncbi.nlm.nih.gov

This is interesting for patient-driven experimentation, although it is more of a research/app project than a mature clinical-trial infrastructure platform.

5. Trialist

Trialist was designed around personalized comparative-effectiveness studies, particularly chronic pain. The literature describes a workflow where patients could design personalized comparisons, track symptoms, and generate results for discussion with clinicians.pmc.ncbi.nlm.nih.gov

It's historically important, but I'd distinguish it from currently accessible platforms such as StudyU.

6. N-of-1 Health

N of 1 Health takes a somewhat different approach: it focuses on genetic medicine and longitudinal patient data, combining health-data sources with disease-specific outcomes and personalized research.www.nof1health.com

So this is closer to a personalized-medicine/data platform than a classical randomized crossover N-of-1 trial engine.

If you're evaluating platforms for a new personalized-medicine product

I'd separate the requirements into six layers:

1. Study design — AB/BA, ABAB, multiple crossover, adaptive designs, randomization
2. Intervention management — medication, behavioral intervention, supplement, device, etc.
3. High-frequency longitudinal data — PROs, wearables, sensors, EHR
4. Individual-level statistics — treatment effect, carryover, autocorrelation, time-series models
5. Clinical workflow — clinician review, consent, safety monitoring, reporting
6. Population aggregation — ability to combine many N-of-1 experiments into hierarchical/meta-analytic evidence

That last layer is especially important: a mature personalized-medicine platform ideally supports both the individual experiment and the ability to learn across many individuals. The literature explicitly identifies N-of-1 designs as useful for individual treatment decisions while also allowing results from multiple individuals to contribute to broader evidence.pmc.ncbi.nlm.nih.gov

If your goal is to build or select an actual platform, StudyU is the most directly aligned with a configurable N-of-1 workflow; N-of-1 Hub is more appropriate when you want expert trial-design/analysis services; and Eureka/DCT platforms become more relevant when you need to run large numbers of personalized studies at scale.

Yes—but there’s an important distinction: true N-of-1 trial platforms are still a small niche, while personalized-medicine platforms (especially pharmacogenomics/clinical decision support) are much more mature.

N-of-1 / individualized-treatment platforms

• studyu.health — Probably the clearest match. It provides a web-based N-of-1 Designer plus participant app for specifying, running, monitoring, and analyzing individualized trials. It is open source and designed for researchers/clinicians as well as personalized health experiments.StudyU+1
• github.com — Useful if you're looking for something you can actually extend or self-host. The platform includes both the study designer and participant app.GitHub
• Trialist — A newer consumer-oriented N-of-1 tool that uses Apple Health data to compare an intervention period against an individual's baseline. It is considerably narrower than StudyU but interesting for quantified-self/personalized intervention workflows.Trialist
• PACO / movisensXS / similar mHealth research platforms — These can collect intensive longitudinal individual-level data and support customizable experiments, but historically haven't provided the complete N-of-1 design → execution → statistical-analysis loop that StudyU does.JMIR

Personalized medicine / clinical decision-support platforms

These aren't necessarily N-of-1 trial engines, but they're relevant if by "personalized medicine workflow" you mean patient-specific treatment selection.

• genxys.com — Pharmacogenomic clinical decision support integrated with EHR/EMR/pharmacy workflows. It uses genotype plus clinical information to identify personalized medication options.GenXys
• PrecisionRx AI — A newer precision-medicine/CDS platform combining genomic, laboratory, medication, wearable, phenotype and EHR signals. It explicitly describes a specialist therapeutics environment for N-of-1 and ultra-rare-disease therapies, although its own site characterizes the product as a concept-phase/SaMD-track platform.PrecisionRx AI+1
• PREDICT / Vanderbilt's PGx infrastructure — More of an institutional implementation than a commercial platform, but an important example of a production personalized-medicine workflow: genotype → phenotype → evidence/rules → EHR clinical decision support.PubMed Central (PMC)
• CLIPMERGE PGx — Another institutional example that combines genotype and longitudinal EHR data and delivers genome-informed recommendations directly within clinical workflow.

How I'd categorize the landscape

The interesting gap is a platform that combines the N-of-1 experimental loop—hypothesis → personalized intervention → repeated measurements → adaptive/crossover design → individual causal inference—with clinical data, genomics, medications, wearables, and clinician workflow. The literature has explicitly identified this as a difficult but desirable architecture; conventional clinical-trial systems generally aren't designed for it.Effective Healthcare

If you're evaluating these platforms for building a product/research program, I can also map the landscape by API availability, adaptive-trial capabilities, Bayesian/statistical engines, EHR/FHIR integration, wearables, genomics, and regulatory/clinical-use status.

N-of-1 therapy designs (single-participant, multiple-crossover trials) and personalized medicine workflows rely on specialized digital tools, open-source frameworks, and clinical research services to track longitudinal, individual-level responses.jmir.org+3

The primary platforms and software ecosystems supporting these workflows include:

• StudyU Platform : An open-source framework specifically built for digital N-of-1 trials . It consists of the StudyU Designer (a collaborative web application for researchers, clinicians, and scientists to configure study metadata, intervention schedules, and consent forms) and the StudyU App (a cross-platform mobile app allowing participants to log observations anonymously and view automated in-app linear regression or graphical results). You can explore the project via StudyU - Personalized Health Interventions.pmc.ncbi.nlm.nih.gov+1
• N-of-1 Hub : A specialized consultancy and clinical service provider focused on single-case experimental designs (SCEDs) and N-of-1 trials. They offer end-to-end data management, randomization sequence generation, HIPAA-compliant secure database setup, and advanced statistical modeling (such as time-series and dynamic regression via R or SPSS) to craft individual patient reports. Details are accessible at N-of-1 Hub.n-of-1hub.com+1
• Digital Infuzion (N-of-1 Health Research Platform) : An enterprise-grade, real-time, patient-centric architecture designed to scale individual patient outcomes tracking alongside larger observational registries. It integrates patient-reported outcomes with regulatory-compliant Electronic Data Capture (EDC) and Electronic Medical Records (EMR) via a mobile-friendly web portal. More on their framework is found at Digital Infuzion.digitalinfuzion.com
• GNU Health : A libre/open-source digital health ecosystem that scales from primary care electronic medical records (EHR) up to precision and molecular-based personalized medicine [3.2., GNU Health]. While not strictly an automated crossover trial builder, its comprehensive architecture supports individual health profiles, laboratory information, and genomic data tracking necessary for custom treatment adjustments. Further details are indexed in the European Commission's Interoperable Europe repository [GNU Health].

Would you like to explore how to set up an open-source trial on StudyU , or are you looking for guidance on the statistical modeling (like time-series or Bayesian approaches) used for analyzing N-of-1 data?

Platforms for n-of-1 trial design and personalized medicine workflows fall into a few categories: dedicated n-of-1 platforms, decentralized clinical trial (DCT) platforms that can support individualized studies, and AI/precision-medicine systems that adapt treatment using patient-specific data.

Dedicated n-of-1 trial platforms

Platform	Best suited for	Key capabilities
StudyU	Researchers, clinicians, digital health studies	Open-source platform with a study designer, participant app, protocol creation, intervention tracking, and analysis/reporting workflows for digital n-of-1 trials.PubMed Central (PMC)+1
Trialist	Patient-centered comparative effectiveness studies	Designed for patients to compare interventions over time (for example, chronic pain interventions), with symptom tracking and individual-level analysis. It has been used in research but is not broadly available today.PubMed Central (PMC)+1
StudyMe	Self-experimentation and patient-driven research	Mobile workflow for defining goals, interventions, measurements, schedules, running trials, and viewing individual results.PubMed Central (PMC)
N of One	Consumer/personal science workflows	Supports protocol selection/design, data collection, and individual response analysis for self-directed experiments.N of One

Decentralized clinical trial and digital health platforms

These are not always "pure" n-of-1 systems, but they provide many of the building blocks: mobile apps, sensor data, patient-reported outcomes, remote monitoring, and analytics.

Platform	Typical use
Eureka Research Platform	Mobile health research, including individualized studies. It provides participant apps, study management, secure data storage, and analysis infrastructure; it has been used to support n-of-1 trials such as I-STOP-AFib.PubMed Central (PMC)+1
Evidation	Remote patient monitoring, real-world evidence, and decentralized studies.PubMed Central (PMC)

Precision medicine / adaptive treatment platforms

These focus less on classic n-of-1 randomized crossover trials and more on continuously optimizing treatment using an individual's biological or clinical data.

Platform	Approach
CURATE.AI	Uses patient-specific dose–response models ("avatars") to personalize therapy selection and dosing, especially in oncology and other areas where treatment response evolves over time.PubMed Central (PMC)

General clinical research systems that can be adapted

Some electronic data capture (EDC), clinical trial management, and patient-reported outcome systems can support n-of-1 workflows if customized:

• OpenClinica — useful for protocol-based data collection, though historically not designed specifically for n-of-1 analysis/reporting.JMIR
• REDCap — commonly used for clinical research data collection; n-of-1 workflows usually require custom forms, randomization logic, and analysis pipelines.

Features to look for in an n-of-1 platform

A mature platform typically supports:

• Individual trial design (ABAB, crossover, randomized sequences, adaptive designs)
• Treatment/intervention scheduling
• Patient-reported outcomes (PROMs)
• Wearable and sensor integration
• Medication tracking
• Randomization/blinding where appropriate
• Bayesian or time-series analysis
• Individual response visualization
• Clinician–patient shared decision-making reports
• Data export and interoperability (FHIR, APIs, CSV)

effectivehealthcare.ahrq.govIf you are evaluating platforms for a clinical practice workflow, academic research, biotech drug development, or a patient-facing app, the shortlist would differ substantially.